[MO3] Mini-Oral Session 3　Gastrointestinal Cancer 1（Upper GI Tract 1）
【E】

[MO3-3] Efficacy and safety of definitive chemoradiotherapy in patients with unresectable locally advanced esophageal SCC

^○Ryosuke Kumanishi¹, Takatsugu Ogata¹, Takumi Habu², Hideaki Bando³, Takeshi Fujisawa⁴, Shogo Kumagai², Hisashi Fujiwara⁵, Saori Mishima³, Daisuke Kotani³, Masaki Nakamura⁴, Hidehiro Hojo⁴, Shohei Koyama², Hiroyoshi Nishikawa², Tomonori Yano⁶, Takeo Fujita⁵, Shigenori Kadowaki¹, Takahiro Kinoshita⁷, Masahiro Tajika⁸, Kei Muro¹, Takashi Kojima³ (1.Department of Clinical Oncology, Aichi Cancer Center Hospital, 2.Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Kashiwa, Japan, 3.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 4.Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Kashiwa, Japan, 5.Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Japan, 6.Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan, 7.Department of Surgical Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 8.Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan)